EnteroMedics (ETRM) Reports Q2 Loss of $0.49/Share

EnteroMedics (NASDAQ: ETRM) reported Q2 EPS of ($0.49), versus ($1.49) reported last year. Revenue for the quarter came in at $276 thousand, versus $79 thousand reported last year.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c